- Home
- PYPL vs ZTS Comparison
PYPL vs ZTS Comparison
Compare PYPL & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPL
- ZTS
- Stock Information
- Founded
- PYPL 1998
- ZTS 1952
- Country
- PYPL United States
- ZTS United States
- Employees
- PYPL N/A
- ZTS N/A
- Industry
- PYPL Business Services
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- PYPL Consumer Discretionary
- ZTS Health Care
- Exchange
- PYPL Nasdaq
- ZTS Nasdaq
- Market Cap
- PYPL 71.9B
- ZTS 73.2B
- IPO Year
- PYPL 2002
- ZTS 2013
- Fundamental
- Price
- PYPL $77.98
- ZTS $152.01
- Analyst Decision
- PYPL Buy
- ZTS Buy
- Analyst Count
- PYPL 33
- ZTS 8
- Target Price
- PYPL $84.03
- ZTS $204.00
- AVG Volume (30 Days)
- PYPL 9.0M
- ZTS 3.1M
- Earning Date
- PYPL 07-29-2025
- ZTS 08-05-2025
- Dividend Yield
- PYPL N/A
- ZTS 1.31%
- EPS Growth
- PYPL 11.79
- ZTS 7.32
- EPS
- PYPL 4.45
- ZTS 5.57
- Revenue
- PYPL $31,889,000,000.00
- ZTS $9,286,000,000.00
- Revenue This Year
- PYPL $4.75
- ZTS $3.45
- Revenue Next Year
- PYPL $5.69
- ZTS $6.16
- P/E Ratio
- PYPL $17.52
- ZTS $27.30
- Revenue Growth
- PYPL 4.79
- ZTS 6.32
- 52 Week Low
- PYPL $55.85
- ZTS $139.70
- 52 Week High
- PYPL $93.66
- ZTS $200.33
- Technical
- Relative Strength Index (RSI)
- PYPL 64.19
- ZTS 42.20
- Support Level
- PYPL $71.73
- ZTS $147.25
- Resistance Level
- PYPL $76.23
- ZTS $154.04
- Average True Range (ATR)
- PYPL 1.84
- ZTS 3.06
- MACD
- PYPL 0.30
- ZTS 0.01
- Stochastic Oscillator
- PYPL 89.65
- ZTS 32.78
About PYPL PayPal Holdings Inc.
PayPal was spun off from eBay in 2015 and provides electronic payment solutions to merchants and consumers, with a focus on online transactions. The company had 434 million active accounts at the end of 2024. The company also owns Venmo, a person-to-person payment platform.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.